过去一年中添加的文章,按日期排序

Dermatitis bullosa caused by the immune checkpoint inhibitor camrelizumab: A case report

Y Jiang, L Wu, X Yang, B Ning, N Peng, X Zhu - Frontiers in Medicine - frontiersin.org
287 天前 - … Therefore, multidisciplinary collaboration, close monitoring, regular evaluations,
timely glucocorticoid interventions, and specialised skin therapy are crucial in managing such …

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology

K Krishna, J Vedika, B Kshitij, M Bhushan, P Roshan… - Cureus, 2023 - search.proquest.com
298 天前 - … a rare autoimmune blistering disorder that primarily affects the skin and mucous
membranes. Conventional treatments for PV, such as corticosteroids and immunosuppressive …

A Rare Case of Pertuzumab-Induced Toxic Epidermal Necrolysis

MJM Zakee, CP Felipe, MA Perozo, R Napat… - Cureus, 2023 - search.proquest.com
298 天前 - … Early withdrawal of suspected drugs, supportive care, and the use of corticosteroids
and other immunomodulators can help manage this condition. Further research on the …

[HTML][HTML] Bullous pemphigoid in a previously healthy adolescent: a case report and literature review

N Giacaman, RSN Abusaada, SM Tos… - Annals of Medicine …, 2023 - journals.lww.com
305 天前 - … BP is the most prevalent autoimmune bullous illness, caused by autoantibodies
against … time, systemic therapy is an option. Systemic glucocorticoids should be used in severe …

Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China

JL Zhang, SH Wang, SN Cui, J Zhang… - The Journal of …, 2023 - Wiley Online Library
306 天前 - … a Prednisone dose ≥0.5 mg/kg per day applied during the autoimmune bullous
diseases (AIBDs) disease course. Values are expressed as number (percentage) or mean±…

Case report of therapy resistant bullous pemphigoid.

M Bognár, C Gyömörei, V Kiss, A Hanyecz - 2023 - cabidigitallibrary.org
308 天前 - blisters developed. Early clinical presentation indicated Sweet syndrome or IgA-mediated
autoimmune bullous diseases… usual immunosuppressant therapy - corticosteroid and …

Clinical Features and Management of Dermatologic Immune-Related Adverse Events for the Inpatient Dermatologist

CJ Fay, C Iriarte, BS Allais, CE Pisano, A Jfri… - Current Dermatology …, 2023 - Springer
316 天前 - … pustulosis, and autoimmune bullous disease. We also review other … used for more
extensive eruptions with prednisone used to calm severe toxicity temporarily while a steroid

Oral Jak Inhibitor Upadacitinib Use in Treatment of Pemphigus Foliaceus: Case Report

S Guenin, S Shah, M Lebwohl - SKIN The Journal of Cutaneous …, 2023 - jofskin.org
317 天前 - … Pemphigus foliaceus (PF) is a variant of pemphigus, a rare, blistering autoimmune
… which consist of long-term corticosteroid use and intravenous rituximab treatments. Further …

Intravenous Immunoglobulin for Autoimmune Bullous Diseases: A Case Series from a Central European Referral Center

MM Spałek, M Bowszyc-Dmochowska, M Dmochowski - Medicina, 2023 - mdpi.com
326 天前 - … In our calculations of prednisone equivalent dosage, we excluded one patient
with PV (#1) (Figure 2) who, due to contraindications (active hepatitis C viremia treated with …

An Orbital Manifestation of VEXAS Syndrome

A Lokhande, S Jarmale, YJ Vaishnav… - Ophthalmic Plastic & …, 2023 - journals.lww.com
328 天前 - … of the disease with other autoimmune disorders such as … responded to oral
glucocorticoid therapy. Visual acuity was … a high-dose oral prednisone taper with resolution of his …